Trial Profile
A pharmacokinetic and pharmacodynamic study of valganciclovir in solid organ transplant patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Sep 2012
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Pharmacokinetics
- 21 Sep 2012 Disease descriptor added - cytomegalovirus infections (pr)
- 17 Apr 2007 New trial record.